Angiogenesis model with carrying capacity depending on vessel density

Journal of Biological Systems

Volumn 17, Issue 1, 2009, Pages 1-25

  Bodnar, Marek ^a   Foryś, Urszula ^a  

^a UNIVERSITY OF WARSAW   (Poland)

Author keywords

Angiogenesis; Antiangiogenic therapy; Cusp catastrophe; Hysteresis effect; Local stability; Ordinary and delay differential equations; Steady states; Vascular and avascular tumor

Indexed keywords

EID: 65249153022     PISSN: 02183390     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0218339009002739     Document Type: Article

References (37)

1. Folkman J, Tumor angiogenesis: Therapeutic implications, N Engl J Med 285:1182-1186, 1971.
2. Folkman J, Angiogenesis, Ann Rev Med 57:1-18, 2006.
3. O'Reilly MS et al., Agiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma, Cell 79:315-328, 1994.
4. O'Reilly MS et al., Endostatin: An endogenous inhibitor of angiogenesis and tumor growth, Cell 88:277-285, 1997.
5. Folkman J, Agiogenesis in cancer, vascular, rheumatoid and other disease, Nat Med 1(1):27-31, 1995.
6. Carmeliet P, Jain RK, Angiogenesis in cancer and other diseases, Nature 407:249-257, 2000.
7. Yangopoulos CD, Davis S, Gale NW et al., Vascular-specific growth factors and blood vessel formation, Nature 407:242-248, 2000.
8. Holash SJ, Wiegandand GD, Yancopoulos GD, New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF, Oncogene 18:5356-5362, 1999.
9. Agur Z, Arakelyan L, Daugulis P, Ginosar Y, Hopf point analysis for angiogenesis models, Disrete & Cont Dyn Sys B 4(1):29-38, 2004.
10. Arakelyan L, Vainstein V, Agur Z, A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumor growth, Angiogenesis 5:203-214, 2002.
11. Mantzaris NV,Webb S, Othmer HG, Mathematical modeling of tumor-induced angiogenesis, J Math Biol 49(2):111-187, 2004.
12. Preziosi L (ed.), Cancer Modeling and Simulation, Chapman & Hall 2003.
13. Hahnfeldt P, Panigrahy D, Folkman J, Hlatky L, Tumor development under angiogenic signaling: A dynamical theory of tumor growth, treatment response and postvascular dormancy, Cancer Res 59:4770-4775, 1999.
14. d'Onofrio A, Gandolfi A, Tumor eradication by antiangiogenic therapy: Analysis and extensions of the model by Hahnfeldt et al. (1999), Math Biosci 191:159-184, 2004.
15. d'Onofrio A, Gandolfi A, A family of models of angiogenesis and antiangiogensis anticancer therapy, Math Med Biol, accepted.
16. d'Onofrio A, Gandolfi A, The response to antiangiogenic anticancer drugs that inhibit endothelial cell proliferation, Appl Math Comput 181(2):1155-1162, 2006.
17. Ergun A, Camphausen K, Wein LM, Optimal scheduling of radiotherapy and angiogenic inhibitors, Bull Math Biol 65:407-424, 2003.
18. Ledzewicz U, Scḧattler H, Analysis of a mathematical model for tumor antiangiogenesis, Opt Control Appl Meth 29:41-57, 2008.
19. Ledzewicz U, Scḧattler H, Antiangiogenic therapy in cancer treatment as an optimal control problem, SIAM J Contr Optim 46(3):1052- 1079, 2007.
20. Ledzewicz U, Scḧattler H, Optimal and suboptimal protocols for a class of mathematical models for tumor anti-angiogenesis, J Theor Biol 252(2):295-312, 2008.
21. Świerniak A, Comparison of six models of antiangiogenic therapy, Appl Math, accepted.
22. Świerniak A, Gala G, Gandolfi A, d'Onofrio A, Optimization of anti-angiogenic therapy as optimal control problem, in Doblaré M (ed.), Proc 4th IASTED Conf. on Biomechanics, ACTA Press, pp. 56-60, 2006.
23. Swierniak A, dOnofrio A, Gandolfi A, Control problems related to tumor angiogenesis, in Proc. IEEE Industrial Electronics-IECON2006, Paris, November 6-10, pp. 677-681, 2006.
24. Gilead A, Neeman M, Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice, Neoplasia 1:226-230, 1999.
25. Foryś U, Kheifetz Y, Kogan Y, Critical point analysis for three-variable cancer angiogenesis models, Math Biosci Eng 2(3):511-525, 2005.
26. Arakelyan L,Merbl Y, Agur Z, Vessel maturation effects on tumour growth: Validation of a computer model in implanted human ovarian carcinoma spheroids, Eur J Cancer 41:159-167, 2005.
27. Bartha K, Rieger H, Vascular network remodeling via vessel cooption, regression and growth in tumors, J Theor Biol 241(4):903-918, 2006.
28. Welter M, Bartha K, Rieger H, Emergent vascular network inhomogeneities and resulting blood flow patterns in a growing tumor, J Theor Biol 250(2):257-280, 2008.
29. Greenspan HP, Models for the growth of solid tumour by diffusion, Stud Appl Math 52:317-340, 1972.
30. Foryś U, Two dimensional cancer angiogenesis model, in Proceedings of the XII National Conference on Application of Mathematics in Biology and Medicine, High School of Comupter Techniques and Telecommunication in Kielce, Kielce 2006.
31. Murray JD, Mathematical Biology I: An Introduction, Springer Verlag, New York, 2002.
32. Bassukas ID, Comparative Gompertzian analysis of alterations of tumor growth patterns, Cancer Res 54:4385-4392, 1994.
33. Foryś U, Marciniak-Czochra A, Logistic equation in tumour growth modelling, Int J Appl Math Comp Sci 13(3):317-325, 2003.
34. Krug H, Taubert G, Zur praxis der anpassung der logistichen function an das wachstum exprerimenteller tumoren, Arch Geschwulstforsch 55:235-244, 1985.
35. Laird AK, Dynamics of tumour growth, Br J Cancer 18:490-502, 1964.
36. Laird AK, Dynamics of tumour growth: Comparison of growth rates and extrapolation of growth curve to one cell, Br J Cancer 19:278-291, 1965.
37. Schuster R, Schuster H, Reconstruction models for the Ehrlich Ascites Tumor for the mouse, in Arino O, Axelrod D, Kimmel M (eds.) Mathematical Population Dynamics, Vol. 2, pp. 335-348, Wuertz, Winnipeg, Canada, 1995.